Ryner Lai, MBBS

Ryner Lai, MBBS

Dr Ryner Lai (MBBS) is a medical graduate from Queen Mary, University of London. He is a medical writer who is passionate about the power of medical research to transform the lives of patients.

All articles by Ryner Lai, MBBS

blood in test tubes

High KL-6 Level Associated With Disease Progression in IPF

Researchers have discovered that serum Krebs von den Lungen-6 (KL-6) level may be a useful biomarker of disease progression in idiopathic pulmonary fibrosis (IPF), as published in Scientific Reports. IPF is a progressive fibrosing interstitial pneumonia that carries a poor prognosis, with a median survival of only 3 to 5 years. Currently, physiological parameters obtained…

sinuses

Study Highlights Need to Manage Sinonasal Symptoms in CF

Researchers reported that there was still a disparity between objective and patient-based measures of chronic rhinosinusitis in individuals with cystic fibrosis (CF) who were treated with highly effective modulator therapy, and published their findings in the International Forum of Allergy & Rhinology. One of the keys to boosting the quality of life in patients with…

group

People With Rare Diseases Report Facing Stigma, Poor Quality of Life

People with rare diseases who live in the United States have a poor health-related quality of life and experience significant stigma, according to a study published in the Orphanet Journal of Rare Diseases. A rare disease in the United States can be defined as any disease in which the prevalence is less than 200,000 cases.…

liver disease

Modified APRI Score as a Noninvasive Tool for Diagnosing CFRLD

Researchers discovered that the modified aspartate aminotransferase-to-platelet ratio index score (mAPRI) is a highly specific and noninvasive tool for the diagnosis of cystic fibrosis-related liver disease (CFRLD), as published in Clinical Transplantation. Despite the fact that liver disease is a significant cause of morbidity and mortality in patients with cystic fibrosis (CF), there is still no…

Next post in SCD Insights